DENTSPLY Sirona (XRAY) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does DENTSPLY Sirona (XRAY) do?
DENTSPLY Sirona Inc (XRAY) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Produces digital imaging systems, treatment chairs, and restoration equipment for clinical practices. Manufactures consumable dental products and equipment used by dentists and laboratories worldwide. It is worth $1.68B on the market and sold $3.58B over the last year.
- Market cap
- $1.68B
- P/E ratio
- None (reported a loss)
- Annual sales
- $3.58B
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Brief updated
- Nov 19, 2026
Brands and businesses behind XRAY
- CEREC: Chairside dental CAD and CAM systems sold to clinics for same-day crowns and restorations.
- SureSmile: Clear aligner system providing custom orthodontic treatment plans sold directly to dental practices.
- Astra Tech Implant System: Dental implant line generating revenue through surgical fixtures, abutments, and restorative components.
- Cavitron: Ultrasonic scaling equipment and insert tips used by hygienists for routine teeth cleanings.
- WaveOne: Reciprocating endodontic file system sold to specialists for root canal procedures.
- Nupro: Prophylaxis pastes and fluoride varnishes purchased regularly by clinics for patient preventive care.
XRAY’s flags, in plain English
Each flag is a number from DENTSPLY Sirona’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 19, 2026.
Stupid Cash
Can pay this year's bills 1.6 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Wide Gross Margin
Gross margin of 50.5% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Cheap on Cash Flow
Priced at 16.3 times the cash it generates each year. The share price is low compared with the cash the business actually brings in, and cash is harder to dress up than profit.
Debt Is Driving
Heavy debt, 169% of shareholder equity. The company owes a lot compared with what it earns. Lenders get paid before shareholders, which leaves management fewer options in a weak year.
2 more risk notes open with the free trial. Try it free for 7 days.
Questions about XRAY
How big is DENTSPLY Sirona?
DENTSPLY Sirona’s market cap is $1.68B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $3.58B: what customers paid the company over the last year, before any costs.
What is XRAY’s P/E ratio?
XRAY has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with XRAY?
A large portion of elective dental treatments depends on out-of-pocket consumer spending, which softens during broader economic slowdowns. That is one risk on DENTSPLY Sirona’s card. Its first risk flag is Debt Is Driving, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From DENTSPLY Sirona’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. XRAY’s filings on SEC.gov. The Margin Monkey is research, not advice.
